Learn more about us

Our Company

The Center of Genetic Analysis and Prognosis – or CoGAP® for short - is a German company with headquarters located on Lungengasse in the heart of Cologne. The company was founded in 2009 as a private corporation under civil law by Dr. Hossein Askari, attorney Robert Tubis, LL.M.oec. and physician Dr. Holger Thiele and since then has been devoted to the development of genetic analyses. In mid-2010, the CoGAP GmbH was entered in the commercial register.

Our objective is to provide you with specialized genetic analyses for health optimization; we evaluate the latest discoveries in the area of human genetics and incorporate them into a practical application. CoGAP® allows you to tailor your health care to match your specific needs, and select the optimal health care recommendations for you from the universe of available health care advice. The focus is on your individual well-being and the opportunity provided by CoGAP® for personalized health care.

Our philosophy

Thanks to the major advances in human genetics that have taken place in recent years, it has now become possible to use new technologies to examine the human genome or DNA. Such testing can provide a wide range of information about metabolism, one’s state of health and health risks and other biological processes in the human body. Until now, this information has been used primarily for specific medical purposes.

In contrast, the objective of CoGAP® is to make these scientific discoveries accessible for healthy individuals to use in their everyday lives in form of genetic analyses. True to the fundamental philosophy of CoGAP® to enable personalized health care, this allows each person to optimize their individual health care and well-being according to the individual genetic make-up.

We focus exclusively on developing such lifestyle analyses, which are scientifically grounded and ethically appropriate. An analytic test is only incorporated into the services offered by CoGAP® if the analytic results contribute to improving an individual’s general state of health and to enabling that individual to continue living a healthy life into old age.

In addition, to assure maximum data security, we only work with selected CoGAP partners who have committed themselves contractually and professionally to protecting client confidentiality. These partners will send your DNA sample to us only in anonymized form. Thus, your identity remains unknown to CoGAP® itself – and also to any third parties that may be contracted by us. Even so, we also treat the anonymized analytic results in strict confidence and release them only to our CoGAP partners. Our CoGAP partners do not have access to the raw genetic data itself.


Dr. Hossein Askari

He studied biology with specializations in genetics and biochemistry through 2008 at the University of Cologne. Along with his studies, Dr. Hossein Askari worked at the Cologne Center for Genomics in the areas of SNP genotyping, DNA sequencing, and the statistical evaluation and analysis of human genetic data. In addition, he was engaged at the Miltenyi Biotec/Research Marketing firm and at the Institute for Quality and Efficiency in Health Care (IQWiG) in Cologne in the area of non-drug interventions. Also he obtained his Ph.D. degree in the field of entrepreneurship in medical biotechnology at the “Schumpeter School of Business and Economics” and is currently lecturer at the “Fresenius University of Applied Sciences in Cologne” for the subject of “Entrepreneurial Finance and Business Development”. Furthermore Dr. Askari is the CEO of CoGAP GmbH.

Robert Tubis, LL.M.oec.

He studied law at the Philipps University of Marburg through 2005. Along with his studies, he founded and ran a retail business together with fellow students. Between 2005 and 2006 he earned his additional qualification in pharmaceutical law at the Philipps University of Marburg. As part of his legal internship at the Aachen District Court, Robert Tubis worked for leading law firms in Düsseldorf and London. Since 2008, he has been admitted to practice of law in Cologne and until 2010 he worked at the Oppenhoff & Partner law firm, specializing in litigation and arbitration, providing legal consultation primarily to international pharmaceutical firms. From 2008 to 2009, he completed advanced studies in business law and earned an additional master degree (LL.M.oec.) at the University of Cologne. Robert Tubis currently works as an attorney and as a legal adviser for the CoGAP GmbH.

Dr. med. Holger Thiele

He studied medicine at the Humboldt University of Berlin (Charité) until 1999. He earned his doctorate in the same year for an experimental dissertation on the subject “Structure and function of the gene for the translationally controlled tumor protein (tctp).” From 1999 to 2004, Dr. Thiele worked as a research associate at the Institute for Human Genetics at the Charité, at the Max Planck Institute for Molecular Biology in Berlin, and at the Gene Mapping Center of the Max Delbrück Center for Molecular Medicine in Berlin. Since November 2004, he has been the technical director of the Cologne Center for Genomics (CCG) in Cologne. In addition, Dr. Thiele serves as the medical director of the CoGAP GmbH.

Advisory board

Prof. Dr. Peter Nürnberg

  • Professor of Genetics, University of Cologne
  • Director of the Cologne Center for Genomics, University of Cologne
  • Managing director of Atlas Biolabs GmbH, Berlin

Prof. Dr. Klaus Nathusius

  • Professor of Entrepreneurship, Kassel University
  • Lecturer in Entrepreneurship & Entrepreneurial Finance, Georg-August University of Göttingen
  • Managing director GENES GmbH Venture Services, Frechen

Dr. Herbert Schmitz

  • Management consultant, Cologne
  • Member of the executive board of the Association for the Promotion of Business Management Studies at the University of Cologne
  • Until February 2010 Chief Operating Officer (COO) and Human Resources Director at the Gothaer Insurance Company, Cologne

Function of the advisory board of the CoGAP GmbH
The advisory board of the CoGAP GmbH supports the management in its mission to stabilize and further develop the company, specifically through consultancy in the development and marketing of lifestyle analyses and provides information regarding trends in the health sector.

Members of the advisory board
The advisory board consists of three members. These members represent companies and research facilities related to the health sector. This way the CoGAP GmbH profits from the expert know how coming directly from the science and entrepreneurship areas into the service area and can immediately provide this to the customer.